Neogen (NEOG) Expected to Announce Quarterly Earnings on Wednesday

Neogen (NASDAQ:NEOG) is expected to be announcing its earnings results before the market opens on Wednesday, April 9th. Analysts expect the company to announce earnings of $0.13 per share and revenue of $225.27 million for the quarter. Neogen has set its FY 2025 guidance at EPS.

Neogen (NASDAQ:NEOG) last issued its quarterly earnings results on Friday, January 10th. The company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.12. The firm had revenue of $231.30 million during the quarter, compared to the consensus estimate of $227.16 million. Neogen had a positive return on equity of 2.89% and a negative net margin of 52.12%. The business’s revenue was up .7% compared to the same quarter last year. During the same period last year, the business posted $0.11 EPS. On average, analysts expect Neogen to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Neogen Stock Down 3.2 %

Shares of NASDAQ:NEOG opened at $8.39 on Wednesday. Neogen has a 1 year low of $8.04 and a 1 year high of $18.58. The company has a debt-to-equity ratio of 0.33, a current ratio of 3.77 and a quick ratio of 2.46. The business’s 50-day moving average is $10.02 and its 200-day moving average is $12.62. The company has a market capitalization of $1.82 billion, a price-to-earnings ratio of -3.83 and a beta of 1.27.

Insider Activity

In other Neogen news, CEO John Edward Adent purchased 23,035 shares of Neogen stock in a transaction that occurred on Thursday, January 16th. The stock was acquired at an average price of $11.03 per share, with a total value of $254,076.05. Following the transaction, the chief executive officer now owns 269,164 shares in the company, valued at $2,968,878.92. This trade represents a 9.36 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO David H. Naemura acquired 14,800 shares of the stock in a transaction on Thursday, January 16th. The shares were acquired at an average price of $11.11 per share, for a total transaction of $164,428.00. Following the acquisition, the chief financial officer now owns 61,434 shares of the company’s stock, valued at approximately $682,531.74. The trade was a 31.74 % increase in their position. The disclosure for this purchase can be found here. 1.13% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Piper Sandler reissued a “neutral” rating and issued a $13.00 price target (down from $16.50) on shares of Neogen in a research note on Tuesday, January 21st. Guggenheim began coverage on shares of Neogen in a research report on Thursday, December 19th. They set a “buy” rating and a $15.00 target price on the stock.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.